Skip to main content
. 2021 Mar 29;34(2):e100423. doi: 10.1136/gpsych-2020-100423

Table 2.

Demographic data and data related to serum concentration of ARI and DARI in men in different groups

Characteristic ARI
group
(n=43)
Comedication
group (n=63)
χ2 P value Comedication
group (n=63)
CLZ (n=31) RIP (n=7) QTP (n=8) OLZ (n=17) χ2 P value
Demographic
 Age, years Mean (SD) Mean (SD) t P value Mean (SD) Mean (SD) Mean (SD) Mean (SD) F P value
36.1 (10.4) 42.3 (12.6) −4.23 <0.001 45.6 (11.2) 29.8 (12.0) 34.6 (15.8) 41.5 (12.0) 10.78 <0.001
Data related to serum concentration
 ARI dose, mg/d 21.4 (7.2) 20.5 (7.1) 0.93 0.36 19.9 (5.5) 25.9 (12.8) 20.0 (3.8) 20.4 (8.0) 1.96 0.10
 Comedication dose, mg/d median
(IQR 25–75)
median
(IQR 25–75)
χ2 P value median
(IQR 25–75)
median
(IQR 25–75)
median
(IQR 25–75)
median
(IQR 25–75)
χ2 P value
113.0 (100.0–163.0) 2.0 (2.0–3.0) 200.0 (150.0–300.0) 10.0 (7.5–10.0)
 ARI concentration, ng/ml 233.6 (134.3–339.5) 237.9 (140.6–316.5) 0.15 0.70 245.7 (166.6–322.4) 260.9 (126.1–324.5) 166.1 (124.4–303.8) 237.0 (137.4–304.6) 1.34 0.86
 DARI concentration, ng/ml 94.1 (47.5–176.5) 110.5 (65.6–151.9) 2.24 0.14 115.3 (80.4–163.5) 89.7 (36.1–171.0) 100.4 (62.0–139.4) 104.3 (65.0–130.7) 6.57 0.16
 ARI+DARI concentration, ng/ml 331.5 (199.2–516.8) 336.1 (227.0–465.7) 0.02 0.90 378.6 (264.5–488.7) 384.1 (184.0–544.2) 265.0 (211.1–443.2) 352.4 (210.1–471.9) 2.48 0.65
 ARI concentration/ARI dose, d/L 12.0 (7.6–16.1) 11.8 (8.2–15.3) 0.03 0.86 12.3 (8.6–15.4) 10.2 (4.4–17.1) 8.5 (5.4–16.2) 11.8 (8.0–14.9) 1.23 0.87
 DARI concentration/ARI dose, d/L 4.8 (2.5–8.3) 5.5 (3.7–7.8) 2.45 0.12 6.8 (4.4–8.2) 2.3 (1.8–7.8) 5.0 (3.1–8.0) 5.1 (3.4–6.3) 9.41 0.05
 ARI+DARI concentration/ARI dose, d/L 16.9 (10.7–24.2) 18.1 (11.9–23.1) 0.15 0.70 19.6 (12.9–23.2) 20.8 (6.0–27.2) 13.3 (10.5–23.7) 16.4 (11.6–22.2) 2.68 0.61

ARI, aripiprazole; CLZ, clozapine; DARI, dehydroaripiprazole; IQR, interquartile range; OLZ, olanzapine; QTP, quetiapine; RIP, risperidone; SD, standard deviation.